| Literature DB >> 34291386 |
Yumi Kosaka1, Tomokazu Kawaoka1, Yutaro Ogawa1, Kei Amioka1, Kensuke Naruto1, Yuki Yoshikawa1, Yuwa Ando1, Yosuke Suehiro1, Kenji Yamaoka1, Yasutoshi Fujii1, Shinsuke Uchikawa1, Atsushi Ono1, Masami Yamauchi1, Michio Imamura1, Keigo Chosa2, Kazuo Awai2, Yasushi Nagata3, Kazuaki Chayama4,5,6, Hiroshi Aikata7.
Abstract
The overall survival of patients with advanced hepatocellular carcinoma with tumor thrombosis of the main trunk or bilobar branches of the portal vein is extremely poor. Moreover, there is no standard treatment established for the condition. Herein, we present the case of a 65-year-old man who were treated the patient with hepatic arterial infusion chemotherapy, radiation therapy for tumor thrombosis, portal vein stent placement, lenvatinib administration, and renal venous shunt embolization. A complete response was observed according to mRECIST and the patient has been alive for 14 months since treatment initiation with no tumor recurrence.Entities:
Keywords: Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Lenvatinib; Portal vein tumor thrombosis; Radiation therapy
Year: 2021 PMID： 34291386 DOI： 10.1007/s12328-021-01481-9
Source DB: PubMed Journal: Clin J Gastroenterol ISSN： 1865-7265